These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 17919235

  • 1. Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.
    Kemp W, Krum H, Colman J, Bailey M, Yandle T, Richards M, Roberts S.
    Liver Int; 2007 Nov; 27(9):1232-9. PubMed ID: 17919235
    [Abstract] [Full Text] [Related]

  • 2. Urotensin II levels are an important marker for the severity of portal hypertension in children.
    Pawar R, Kemp W, Roberts S, Krum H, Yandle T, Hardikar W.
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):88-92. PubMed ID: 21694541
    [Abstract] [Full Text] [Related]

  • 3. Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats.
    Kemp W, Kompa A, Phrommintikul A, Herath C, Zhiyuan J, Angus P, McLean C, Roberts S, Krum H.
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G762-7. PubMed ID: 19797237
    [Abstract] [Full Text] [Related]

  • 4. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [Abstract] [Full Text] [Related]

  • 5. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L, Giostra E, Frossard JL, Morard I, Mentha G, Hadengue A.
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [Abstract] [Full Text] [Related]

  • 6. Increased circulating urotensin II in cirrhosis: potential implications in liver disease.
    Kemp W, Roberts S, Krum H.
    Peptides; 2008 May; 29(5):868-72. PubMed ID: 17913301
    [Abstract] [Full Text] [Related]

  • 7. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus.
    Kumar M, Kumar A, Hissar S, Jain P, Rastogi A, Kumar D, Sakhuja P, Sarin SK.
    Liver Int; 2008 May; 28(5):690-8. PubMed ID: 18433395
    [Abstract] [Full Text] [Related]

  • 8. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease].
    Wang T, Li SX, Zhang XQ, Gu XH, Song Y, Zhang G, Wu SM.
    Zhonghua Yi Xue Za Zhi; 2005 Oct 12; 85(38):2691-5. PubMed ID: 16324296
    [Abstract] [Full Text] [Related]

  • 9. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.
    Heller J, Schepke M, Neef M, Woitas R, Rabe C, Sauerbruch T.
    J Hepatol; 2002 Dec 12; 37(6):767-72. PubMed ID: 12445417
    [Abstract] [Full Text] [Related]

  • 10. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.
    Zomer E, de Ridder I, Kompa A, Komesaroff P, Gilbert R, Krum H.
    Clin Exp Pharmacol Physiol; 2008 Oct 12; 35(10):1147-50. PubMed ID: 18505448
    [Abstract] [Full Text] [Related]

  • 11. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
    Yin J, Leng X, Zhu J.
    Zhonghua Wai Ke Za Zhi; 1995 Sep 12; 33(9):563-5. PubMed ID: 8731881
    [Abstract] [Full Text] [Related]

  • 12. Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial.
    Kemp W, Colman J, Thompson K, Madan A, Vincent M, Chin-Dusting J, Kompa A, Krum H, Roberts S.
    Liver Int; 2009 Mar 12; 29(3):427-33. PubMed ID: 18673434
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
    Rincon D, Lo Iacono O, Ripoll C, Gomez-Camarero J, Salcedo M, Catalina MV, Hernando A, Clemente G, Matilla A, Nuñez O, Bañares R.
    Aliment Pharmacol Ther; 2007 Apr 01; 25(7):841-8. PubMed ID: 17373923
    [Abstract] [Full Text] [Related]

  • 14. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
    Bahr MJ, Böker KH, Horn W, Günzler V, Manns MP.
    Hepatogastroenterology; 1997 Apr 01; 44(16):1200-5. PubMed ID: 9261625
    [Abstract] [Full Text] [Related]

  • 15. Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension.
    Liu D, Chen J, Wang J, Zhang Z, Ma X, Jia J, Wang Y.
    Int J Mol Med; 2010 Jun 01; 25(6):845-51. PubMed ID: 20428787
    [Abstract] [Full Text] [Related]

  • 16. Relationship between the Fibrotest and portal hypertension in patients with liver disease.
    Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenau M, Valla DC, Moreau R, Poynard T, Lebrec D.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):359-68. PubMed ID: 17635370
    [Abstract] [Full Text] [Related]

  • 17. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.
    Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G.
    J Hepatol; 2006 Jan 01; 44(1):111-7. PubMed ID: 16274836
    [Abstract] [Full Text] [Related]

  • 18. Soluble P selectin levels in chronic liver disease: relationship to disease severity.
    Vardareli E, Saricam T, Demirustu C, Gulbas Z.
    Hepatogastroenterology; 2007 Mar 01; 54(74):466-9. PubMed ID: 17523300
    [Abstract] [Full Text] [Related]

  • 19. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
    Dittrich S, Yordi LM, de Mattos AA.
    Hepatogastroenterology; 2001 Mar 01; 48(37):166-8. PubMed ID: 11268957
    [Abstract] [Full Text] [Related]

  • 20. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
    Bellis L, Nicodemo S, Galossi A, Guarisco R, Spilabotti L, Durola L, Dell'Unto O, Puoti C.
    J Gastrointestin Liver Dis; 2007 Sep 01; 16(3):273-7. PubMed ID: 17925921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.